H 
0.65
-7.14%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.56bn
FY2021FY2025
Net income
CN¥55.7m
FY2021FY2025
Free cash flow
CN¥40.2m
FY2021FY2025
Shareholders' equity
CN¥276.7m
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.56bn | CN¥1.02bn | CN¥1.06bn | CN¥483.2m | CN¥431.3m |
| Research and development | CN¥169.0m | CN¥82.3m | CN¥87.8m | CN¥48.9m | CN¥16.8m |
| Operating income | CN¥62.1m | CN¥11.7m | CN¥6.1m | CN¥9.3m | −CN¥69.2m |
| Net income | CN¥55.7m | −CN¥227.9m | −CN¥263.3m | −CN¥219.2m | −CN¥157.2m |
| Diluted earnings per share | 0.06 | -0.26 | -0.30 | -0.25 | -0.18 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | CN¥703.8m | CN¥576.8m | CN¥351.3m | CN¥172.1m | CN¥110.9m |
| Cash and short-term investments | — | — | CN¥143.2m | CN¥59.2m | CN¥37.4m |
| Total liabilities | CN¥420.9m | CN¥345.0m | CN¥1.76bn | CN¥1.40bn | CN¥1.13bn |
| Debt | — | CN¥905,000 | CN¥4.2m | CN¥2.1m | CN¥3.1m |
| Shareholders' equity | CN¥276.7m | CN¥226.8m | −CN¥1.41bn | −CN¥1.23bn | −CN¥1.02bn |
| Shares outstanding | 877m | 878m | 877m | 877m | 877m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | CN¥75.0m | CN¥48.1m | CN¥3.0m | CN¥7.5m | CN¥14.2m |
| Capital spending | −CN¥34.8m | −CN¥64.7m | −CN¥33.2m | −CN¥13.9m | −CN¥445,000 |
| Free cash flow | CN¥40.2m | −CN¥16.6m | −CN¥30.1m | −CN¥6.4m | CN¥13.7m |
Latest quarters
By quarter end
| Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.04bn | CN¥517.9m | CN¥500.4m | CN¥519.2m | CN¥603.2m |
| Operating income | CN¥50.0m | CN¥12.0m | CN¥9.6m | CN¥2.1m | −CN¥11.7m |
| Net income | CN¥48.6m | CN¥7.1m | −CN¥180.5m | −CN¥47.4m | −CN¥176.9m |
| Diluted earnings per share | 0.06 | 0.01 | -0.21 | -0.05 | -0.20 |
| Cash from operations | — | — | CN¥48.0m | CN¥11.0m | CN¥3.0m |
| Capital spending | — | — | −CN¥64.0m | −CN¥16.0m | −CN¥33.0m |
| Free cash flow | — | — | −CN¥16.0m | −CN¥5.0m | −CN¥30.0m |
| Total assets | CN¥703.8m | CN¥554.2m | CN¥489.8m | CN¥343.1m | — |
| Cash and short-term investments | CN¥271.5m | CN¥231.4m | CN¥225.7m | CN¥127.1m | — |
| Debt | CN¥6.4m | CN¥3.5m | CN¥3.9m | CN¥4.0m | — |
| Shareholders' equity | CN¥276.7m | CN¥235.2m | CN¥192.5m | −CN¥1.45bn | — |
Financial ratios
Data as of 20 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating margin | 3.9% | -21.6% | -25.5% | -45.0% | -16.0% |
| Net margin | 3.6% | -22.4% | -24.9% | -45.4% | -36.5% |
| Return on equity | 20.1% | -118.4% | 18.7% | 17.8% | 13.0% |
| Return on assets | 7.9% | -46.5% | -75.0% | -127.4% | -120.4% |
| Free cash flow yield | 14.3% | 10.8% | — | — | — |
| Revenue growth | 30.1% | -3.5% | 118.7% | 31.9% | — |
| Earnings growth | -120.7% | -13.4% | 20.1% | 64.2% | — |
| Current ratio | 1.42x | 1.34x | 0.16x | 0.10x | 0.09x |
| Debt to equity | 0.00x | 0.00x | -0.00x | -0.00x | 0.00x |
| Equity ratio | 39.3% | 39.3% | -400.7% | -715.0% | -923.0% |
| Interest coverage | 26.06x | -1364.82x | -562.28x | -55.13x | -59.63x |
| R&D as a share of sales | 10.8% | 8.1% | 8.3% | 10.1% | 3.9% |
| Buybacks as a share of market value | 0.1% | — | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 48.1% | — | — |
| Operating income | 88.5% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | 59.6 | -26.6 |
| Price to sales | 2.1 | 6.0 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.